New

Angiotensin Receptor Antagonists Market

2021

Angiotensin Receptor Antagonists Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan); Application (Hypertension, Cardiovascular Diseases, Kidney Diseases, Other)

| Report Code: TIPRE00021877 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Angiotensin Receptor Antagonists Market 2028 By Type, Application | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Angiotensin receptor blockers (ARBs) or angiotensin II receptor antagonists, are used to treat cardiac conditions like high blood pressure, heart attack and heart failure. They are also prescribed for chronic kidney disease. Valsartan, losartan and candesartan are examples of angiotensin receptor antagonists.

MARKET DYNAMICS

The angiotensin receptor antagonists market is expected to grow owing to growing prevalence of cardiac conditions and increasing incidence of chronic kidney disease. Moreover, growing pharmaceutical industry across the globe may create growth opportunities for the market.

MARKET SCOPE

The "Angiotensin Receptor Antagonists Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of angiotensin receptor antagonists market with detailed market segmentation by type, and application. The angiotensin receptor antagonists market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in angiotensin receptor antagonists market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The angiotensin receptor antagonists market is segmented on the basis of type, and application. Based on type, the market is segmented as valsartan, telmisartan, losartan, irbesartan, azilsartan, and olmesartan. The application segment is categorized into hypertension, cardiovascular diseases, kidney diseases, and other.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the angiotensin receptor antagonists market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The angiotensin receptor antagonists market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting angiotensin receptor antagonists market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Angiotensin receptor antagonists market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the angiotensin receptor antagonists market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from angiotensin receptor antagonists market are anticipated to have lucrative growth opportunities in the future with the rising demand for angiotensin receptor antagonists in the global market. Below mentioned is the list of few companies engaged in the angiotensin receptor antagonists market.

The report also includes the profiles of key players in angiotensin receptor antagonists market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Pfizer
  •   Novartis
  •   Merck
  •   Astra Zeneca
  •   Johnson and Johnson
    6. Eli Lilly
    7. Sanofi
  •   Bristol-Myers Squibb
  •   Bayer
  •   GSK

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Angiotensin Receptor Antagonists Market - By Type
1.3.2 Angiotensin Receptor Antagonists Market - By Application
1.3.3 Angiotensin Receptor Antagonists Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANGIOTENSIN RECEPTOR ANTAGONISTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANGIOTENSIN RECEPTOR ANTAGONISTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANGIOTENSIN RECEPTOR ANTAGONISTS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANGIOTENSIN RECEPTOR ANTAGONISTS - GLOBAL MARKET OVERVIEW
6.2. ANGIOTENSIN RECEPTOR ANTAGONISTS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. ANGIOTENSIN RECEPTOR ANTAGONISTS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. VALSARTAN
7.3.1. Overview
7.3.2. Valsartan Market Forecast and Analysis
7.4. TELMISARTAN
7.4.1. Overview
7.4.2. Telmisartan Market Forecast and Analysis
7.5. LOSARTAN
7.5.1. Overview
7.5.2. Losartan Market Forecast and Analysis
7.6. IRBESARTAN
7.6.1. Overview
7.6.2. Irbesartan Market Forecast and Analysis
7.7. AZILSARTAN
7.7.1. Overview
7.7.2. Azilsartan Market Forecast and Analysis
7.8. OLMESARTAN
7.8.1. Overview
7.8.2. Olmesartan Market Forecast and Analysis
8. ANGIOTENSIN RECEPTOR ANTAGONISTS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HYPERTENSION
8.3.1. Overview
8.3.2. Hypertension Market Forecast and Analysis
8.4. CARDIOVASCULAR DISEASES
8.4.1. Overview
8.4.2. Cardiovascular Diseases Market Forecast and Analysis
8.5. KIDNEY DISEASES
8.5.1. Overview
8.5.2. Kidney Diseases Market Forecast and Analysis
8.6. OTHER
8.6.1. Overview
8.6.2. Other Market Forecast and Analysis
9. ANGIOTENSIN RECEPTOR ANTAGONISTS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Angiotensin Receptor Antagonists Market Overview
9.1.2 North America Angiotensin Receptor Antagonists Market Forecasts and Analysis
9.1.3 North America Angiotensin Receptor Antagonists Market Forecasts and Analysis - By Type
9.1.4 North America Angiotensin Receptor Antagonists Market Forecasts and Analysis - By Application
9.1.5 North America Angiotensin Receptor Antagonists Market Forecasts and Analysis - By Countries
9.1.5.1 United States Angiotensin Receptor Antagonists Market
9.1.5.1.1 United States Angiotensin Receptor Antagonists Market by Type
9.1.5.1.2 United States Angiotensin Receptor Antagonists Market by Application
9.1.5.2 Canada Angiotensin Receptor Antagonists Market
9.1.5.2.1 Canada Angiotensin Receptor Antagonists Market by Type
9.1.5.2.2 Canada Angiotensin Receptor Antagonists Market by Application
9.1.5.3 Mexico Angiotensin Receptor Antagonists Market
9.1.5.3.1 Mexico Angiotensin Receptor Antagonists Market by Type
9.1.5.3.2 Mexico Angiotensin Receptor Antagonists Market by Application
9.2. EUROPE
9.2.1 Europe Angiotensin Receptor Antagonists Market Overview
9.2.2 Europe Angiotensin Receptor Antagonists Market Forecasts and Analysis
9.2.3 Europe Angiotensin Receptor Antagonists Market Forecasts and Analysis - By Type
9.2.4 Europe Angiotensin Receptor Antagonists Market Forecasts and Analysis - By Application
9.2.5 Europe Angiotensin Receptor Antagonists Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Angiotensin Receptor Antagonists Market
9.2.5.1.1 Germany Angiotensin Receptor Antagonists Market by Type
9.2.5.1.2 Germany Angiotensin Receptor Antagonists Market by Application
9.2.5.2 France Angiotensin Receptor Antagonists Market
9.2.5.2.1 France Angiotensin Receptor Antagonists Market by Type
9.2.5.2.2 France Angiotensin Receptor Antagonists Market by Application
9.2.5.3 Italy Angiotensin Receptor Antagonists Market
9.2.5.3.1 Italy Angiotensin Receptor Antagonists Market by Type
9.2.5.3.2 Italy Angiotensin Receptor Antagonists Market by Application
9.2.5.4 Spain Angiotensin Receptor Antagonists Market
9.2.5.4.1 Spain Angiotensin Receptor Antagonists Market by Type
9.2.5.4.2 Spain Angiotensin Receptor Antagonists Market by Application
9.2.5.5 United Kingdom Angiotensin Receptor Antagonists Market
9.2.5.5.1 United Kingdom Angiotensin Receptor Antagonists Market by Type
9.2.5.5.2 United Kingdom Angiotensin Receptor Antagonists Market by Application
9.2.5.6 Rest of Europe Angiotensin Receptor Antagonists Market
9.2.5.6.1 Rest of Europe Angiotensin Receptor Antagonists Market by Type
9.2.5.6.2 Rest of Europe Angiotensin Receptor Antagonists Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Angiotensin Receptor Antagonists Market Overview
9.3.2 Asia-Pacific Angiotensin Receptor Antagonists Market Forecasts and Analysis
9.3.3 Asia-Pacific Angiotensin Receptor Antagonists Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Angiotensin Receptor Antagonists Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Angiotensin Receptor Antagonists Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Angiotensin Receptor Antagonists Market
9.3.5.1.1 Australia Angiotensin Receptor Antagonists Market by Type
9.3.5.1.2 Australia Angiotensin Receptor Antagonists Market by Application
9.3.5.2 China Angiotensin Receptor Antagonists Market
9.3.5.2.1 China Angiotensin Receptor Antagonists Market by Type
9.3.5.2.2 China Angiotensin Receptor Antagonists Market by Application
9.3.5.3 India Angiotensin Receptor Antagonists Market
9.3.5.3.1 India Angiotensin Receptor Antagonists Market by Type
9.3.5.3.2 India Angiotensin Receptor Antagonists Market by Application
9.3.5.4 Japan Angiotensin Receptor Antagonists Market
9.3.5.4.1 Japan Angiotensin Receptor Antagonists Market by Type
9.3.5.4.2 Japan Angiotensin Receptor Antagonists Market by Application
9.3.5.5 South Korea Angiotensin Receptor Antagonists Market
9.3.5.5.1 South Korea Angiotensin Receptor Antagonists Market by Type
9.3.5.5.2 South Korea Angiotensin Receptor Antagonists Market by Application
9.3.5.6 Rest of Asia-Pacific Angiotensin Receptor Antagonists Market
9.3.5.6.1 Rest of Asia-Pacific Angiotensin Receptor Antagonists Market by Type
9.3.5.6.2 Rest of Asia-Pacific Angiotensin Receptor Antagonists Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Angiotensin Receptor Antagonists Market Overview
9.4.2 Middle East and Africa Angiotensin Receptor Antagonists Market Forecasts and Analysis
9.4.3 Middle East and Africa Angiotensin Receptor Antagonists Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Angiotensin Receptor Antagonists Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Angiotensin Receptor Antagonists Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Angiotensin Receptor Antagonists Market
9.4.5.1.1 South Africa Angiotensin Receptor Antagonists Market by Type
9.4.5.1.2 South Africa Angiotensin Receptor Antagonists Market by Application
9.4.5.2 Saudi Arabia Angiotensin Receptor Antagonists Market
9.4.5.2.1 Saudi Arabia Angiotensin Receptor Antagonists Market by Type
9.4.5.2.2 Saudi Arabia Angiotensin Receptor Antagonists Market by Application
9.4.5.3 U.A.E Angiotensin Receptor Antagonists Market
9.4.5.3.1 U.A.E Angiotensin Receptor Antagonists Market by Type
9.4.5.3.2 U.A.E Angiotensin Receptor Antagonists Market by Application
9.4.5.4 Rest of Middle East and Africa Angiotensin Receptor Antagonists Market
9.4.5.4.1 Rest of Middle East and Africa Angiotensin Receptor Antagonists Market by Type
9.4.5.4.2 Rest of Middle East and Africa Angiotensin Receptor Antagonists Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Angiotensin Receptor Antagonists Market Overview
9.5.2 South and Central America Angiotensin Receptor Antagonists Market Forecasts and Analysis
9.5.3 South and Central America Angiotensin Receptor Antagonists Market Forecasts and Analysis - By Type
9.5.4 South and Central America Angiotensin Receptor Antagonists Market Forecasts and Analysis - By Application
9.5.5 South and Central America Angiotensin Receptor Antagonists Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Angiotensin Receptor Antagonists Market
9.5.5.1.1 Brazil Angiotensin Receptor Antagonists Market by Type
9.5.5.1.2 Brazil Angiotensin Receptor Antagonists Market by Application
9.5.5.2 Argentina Angiotensin Receptor Antagonists Market
9.5.5.2.1 Argentina Angiotensin Receptor Antagonists Market by Type
9.5.5.2.2 Argentina Angiotensin Receptor Antagonists Market by Application
9.5.5.3 Rest of South and Central America Angiotensin Receptor Antagonists Market
9.5.5.3.1 Rest of South and Central America Angiotensin Receptor Antagonists Market by Type
9.5.5.3.2 Rest of South and Central America Angiotensin Receptor Antagonists Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ANGIOTENSIN RECEPTOR ANTAGONISTS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANGIOTENSIN RECEPTOR ANTAGONISTS MARKET, KEY COMPANY PROFILES
12.1. PFIZER
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. NOVARTIS
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. MERCK
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ASTRA ZENECA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. JHONSON AND JOHNSON
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ELI LILLY
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. SANOFI
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BRISTOL-MYERS SQUIBB
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. BAYER
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. GSK
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer
2. Novartis
3. Merck
4. Astra Zeneca
5. Jhonson and Johnson
6. Eli Lilly
7. Sanofi
8. Bristol-Myers Squibb
9. Bayer
10. GSK
TIPRE00021877
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.